Study Links Long-Term Melatonin Use to Increased Heart Failure and Mortality Risks
By
pogue
A bagel you'd recommend to a friend without hedging.
Summary
A preliminary study presented at the American Heart Association's Scientific Sessions 2025 found that long-term melatonin use (one year or longer) for chronic insomnia is associated with significantly increased risks of heart failure, hospitalization for heart failure, and all-cause mortality. Chronic melatonin users were almost twice as likely to die and 3.5 times more likely to be hospitalized for heart failure compared to non-users. The research challenges the widespread perception of melatonin as harmless and urges caution with extended use of the popular sleep supplement.
Key quotes
· 4 pulledadults with chronic insomnia who used melatonin for a year or longer were more likely to develop heart failure, be hospitalized for heart failure, and die from any cause than those who did not take the supplement
chronic users were almost twice as likely to die and 3.5 times more likely to be hospitalized for heart failure
Though melatonin is widely regarded as harmless, experts now urge caution with extended use
Long-term melatonin use for sleep problems may come with unexpected heart dangers
You might also wanna read
Personalized Vitamin D Supplementation Reduces Heart Attack Risk by 52% in Clinical Trial
A new randomized controlled trial called TARGET-D presented at the American Heart Association Scientific Sessions found that personalized vi

Clinical Trial Finds Coffee Consumption Reduces Recurrent Atrial Fibrillation Risk
A multicenter randomized clinical trial (DECAF) involving 200 patients with persistent atrial fibrillation (AF) undergoing cardioversion fou
Study Reveals Myocardial Infarction May Be Caused by Bacterial Infections
A groundbreaking study by Finnish and UK researchers reveals that myocardial infarction (heart attack) may be an infectious disease, challen
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
